Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)

被引:2
作者
Uttarilli, Anusha [1 ,2 ]
Pasumarthi, Divya [1 ]
Ranganath, Prajnya [1 ,3 ]
Dalal, Ashwin B. [1 ]
机构
[1] Ctr DNA Fingerprinting & Diagnost, Div Diagnost, 4-1-714 Tuljaguda Complex,Mozamzahi Rd, Hyderabad 500001, Telangana, India
[2] Manipal Univ, Grad Studies, Manipal, Karnataka, India
[3] Nizams Inst Med Sci, Dept Med Genet, Hyderabad, Telangana, India
关键词
Molecular analysis; Mucopolysaccharidoses type VI; Novel mutation; Functional characterization; Pathogenic variant; Genotype-phenotype correlation; MISSENSE MUTATIONS; GENE; ARSB; N-ACETYLGALACTOSAMINE-4-SULFATASE; IDENTIFICATION; MUTANT;
D O I
10.1016/j.gene.2016.11.005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MPS VI is an autosomal recessive disorder which occurs due to the deficiency of N-acetyl galactosamine-4-sulfatase (Arylsulfatase B - ARSB) involved in catabolism of dermatan sulfate resulting from disease-causing variations in the ARSB gene. Human Gene Mutation Database (HGMD) search revealed 200 different mutations in ARSB worldwide. In the present study we carried out molecular and functional analyses to characterize the mutations reported by us in Indian population. Mutation analysis of 19 MPS VI patients revealed presence of a total of 15 different mutations of which twelve were novel [p.Asp53Asn (c.157G>A; p.D53N), p.Leu98Arg (c.293T>G; p.L98R), p.Tyr103Serfs*9 (c.306_312delCTACCAG+146del; p.Y103Sfs*9), p.Phe166Leufs*18 (c.496delT; p.F166Lfs*18), p.Ile220Serfs*5 (c.659_660delTA; p.I220Sfs*5), p.Ile350Phe (c.1048A>T; p.I350F), p.Trp353* (c.1059G>A; p.W353*), p.His393Arg (c.1178A>G; p.H393R), p.Ser403Tyrfs* (c.1208delC; p.S403Yfs*), p.Pro445Leu (c.1334C>T; p.P445L), p.Trp450Leu (c.1349G>T; p.W450L) and p.Trp450Cys (c.1350G>C; p.W450C)] and three were known mutations [p.Asp54Asn (c.160G>A; p.D54N), p.Ala237Asp (c.710C>A; p.A237D) and p.Ser320Arg (c.960C>G; p.S320R)]. Functional characterization using site-directed mutagenesis followed by cell transfection assays, immunoblot, reverse transcriptase PCR and immunofluorescence studies for the putative pathogenic variants detected in our MPS VI patient cohort helped us to confirm the pathogenic potential of the variants in ARSB. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 24 条
  • [1] Phenylalanine hydroxylase gene mutations in phenylketonuria patients from India: Identification of novel mutations that affect PAH RNA
    Bashyam, Murali D.
    Chaudhary, Ajay K.
    Reddy, E. Chandrakanth
    Devi, A. Radha Rama
    Savithri, G. R.
    Ratheesh, R.
    Bashyam, Leena
    Mahesh, E.
    Sen, Dity
    Puri, Ratna
    Verma, Inder C.
    Nampoothiri, Sheela
    Vaidyanathan, Sunitha
    Chandrashekar, Mataguru D.
    Kantheti, Prameela
    [J]. MOLECULAR GENETICS AND METABOLISM, 2010, 100 (01) : 96 - 99
  • [2] Up to five years experience with 11 mucopolysaccharidosis type VI patients
    Brands, Marion M. M. G.
    Oussoren, Esmee
    Ruijter, George J. G.
    Vollebregt, Audrey A. M.
    van den Hout, Hannerieke M. P.
    Joosten, Koen F. M.
    Hop, Wim C. J.
    Plug, Iris
    van der Ploeg, Ans T.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2013, 109 (01) : 70 - 76
  • [3] Listening to silence and understanding nonsense: Exonic mutations that affect splicing
    Cartegni, L
    Chew, SL
    Krainer, AR
    [J]. NATURE REVIEWS GENETICS, 2002, 3 (04) : 285 - 298
  • [4] Maroteaux-Lamy syndrome:: Functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene
    Garrido, Elena
    Cormand, Bru
    Hopwood, John J.
    Chabas, Amparo
    Grinberg, Daniel
    Vilageliu, Lluisa
    [J]. MOLECULAR GENETICS AND METABOLISM, 2008, 94 (03) : 305 - 312
  • [5] Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs)
    Gorlov, IP
    Gorlova, OY
    Frazier, ML
    Amos, CI
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 554 (1-2) : 175 - 183
  • [6] Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers
    Gorlov, IP
    Gorlova, OY
    Frazier, ML
    Amos, CI
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 1157 - 1161
  • [7] Features of missense/nonsense mutations in exonic splicing enhancer sequences from cancer-related human genes
    Jin, Ping
    Cai, Rongrong
    Zhou, Xiaodan
    Li-Ling, Jesse
    Ma, Fei
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2012, 740 (1-2) : 6 - 12
  • [8] Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutations
    Kantaputra, Piranit Nik
    Kayserili, Hulya
    Guven, Yeliz
    Kantaputra, Warissara
    Balci, Mehmet C.
    Tanpaiboon, Pranoot
    Tananuvat, Napaporn
    Uttarilli, Anusha
    Dalal, Ashwin
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (06) : 1443 - 1453
  • [9] Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI
    Kantaputra, Piranit Nik
    Kayserili, Hulya
    Guven, Yeliz
    Kantaputra, Warissara
    Balci, Mehmet C.
    Tanpaiboon, Pranoot
    Uttarilli, Anusha
    Dalal, Ashwin
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (02) : 263 - 268
  • [10] Mutational analysis of 105 mucopolysaccharidosis type VI patients
    Karageorgos, Litsa
    Brooks, Doug A.
    Pollard, Anthony
    Melville, Elizabeth L.
    Hein, Leanne K.
    Clements, Peter R.
    Ketteridge, David
    Swiedler, Stuart J.
    Beck, Michael
    Giugliani, Roberto
    Harmatz, Paul
    Wraith, James E.
    Guffon, Nathalie
    Teles, Elisa Leao
    Miranda, M. Clara Sa
    Hopwood, John J.
    [J]. HUMAN MUTATION, 2007, 28 (09) : 897 - 903